Skip to Content
Skip to Footer
en-us
italiano
Sign In
Istituto Superiore di Sanità
Follow us on
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
MENU
Istituto Superiore di Sanità
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
Press Room
News
Search Results - News
Search
Search
Asset Entries
Any Asset
Web Content Article
(308)
Tags
Any Tag
coronavirus
(44)
iss per covid 19
(3)
faq vaccini
(2)
vaccini
(2)
Time
Any Time
Past Hour
(0)
Past 24 Hours
(0)
Past Week
(0)
Past Month
(0)
Past Year
(26)
Custom Range…
From
To
Search
No results were found that matched the keywords:
accordo tra Iss e Unicef
.
Search
2021 Pregnancy and breastfeeding: extension of COVID-19 vaccination, update of
ISS
Web Content Article
ISS
, September 24th 2021
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » Cosa fa l'ISS
Covid19: the
ISS
launches two post-vaccination immunological monitoring studies
Web Content Article
ISS
, March 18th 2021 - The aim of two
ISS
studies is to monitor the immune response...The first, in collaboration with the Società Italiana di...
coronavirus
Newsroom:
Special on COVID-19
Press notes
Ethics and anti-COVID vaccine trials, the
ISS
online Report
Web Content Article
The
ISS
COVID-19 Report titled “Ethical Aspects of the experimentation of anti-COVID...by the “COVID-19 Bioethics” Working Group of the Istituto Superiore di Sanità...
Newsroom:
Special on COVID-19
Press notes
COVID-19: data from the
ISS
flash survey in wastewaters confirm prevalence of the
Web Content Article
ISS
, September 8th 2021
Newsroom:
Special on COVID-19
Special on COVID-19 » Acque reflue
PRESS RELEASE no. 10/2022 - Long-COVID: The
ISS
has launched its surveillance project
Web Content Article
ISS
, 9 February 2022 The aim of the CCM project is to monitor the long-term effects..., organized online by the
ISS
....the infection and the test...
Newsroom:
Press notes
Press releases
Special on COVID-19
Special on COVID-19 » Long COVID
Press Release No. 08/2022 COVID-19: Flash survey
ISS
: 95.8% positive Omicron samples
Web Content Article
Leggi la flash survey
Iss
28 January 2022 - On 17 January, in Italy, the Omicron...the results of the flash survey carried out by the Istituto Superiore di Sanità –...
Newsroom:
Press notes
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Press Release No. 68/2022 Pregnancy and Breastfeeding: Update of
ISS
Guidance for
Web Content Article
Leggi il documento
ISS
, 7 October 2022 The Italian Obstetric Surveillance System...Indicazioni ItOSS-
ISS
su vaccinazione in...
Newsroom:
Press notes
Press releases
Special on COVID-19
Press Release No. 57/2022 COVID-19:
ISS
Flash Survey, on 2 August 100% Omicron, 90.8%
Web Content Article
Leggi il bollettino
ISS
, 12 August 2022 In Italy on 2 August, the Omicron variant...These are the results of the flash survey carried out jointly by the...
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Release N°46/2021 Long-term care facilities: COVID-19-related deaths nosedive thanks to vaccines Slight increase in cases in the summer months
Web Content Article
ISS
, September 30th 2021
Newsroom:
Press releases
Special on COVID-19
Press Release N°51/2021 COVID-19: the main monitoring data from the Situation Room
Web Content Article
ISS
, October 8th 2021
Newsroom:
Press releases
Special on COVID-19
Press Release No. 70/2022 COVID19:
ISS
Flash Survey, 100% Omicron on 4 October, Subvariant
Web Content Article
These are the results of the flash survey carried out by the
ISS
and the Ministry
Newsroom:
Press notes
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
PRESS RELEASE N° 41/2021 COVID-19: Guidance on prevention for the reopening of schools and a network of “sentinel schools” to monitor the epidemic
Web Content Article
A strategic document for the prevention and control of SARS-CoV-2 infections and a monitoring plan to control the circulation of the virus in schools have been drawn up to protect classroom teaching.
Newsroom:
Press releases
Special on COVID-19
Press Release N°53/2021 COVID-19: vaccinated individuals who died were 'hyper-fragile', higher average age and had more previous illnesses "Reducing the circulation of the virus is the best way to protect them"
Web Content Article
ISS
, October 19th 2021
Newsroom:
Press releases
Press notes
Special on COVID-19
Press Release N° 34/2021 COVID-19: in Italy the Delta variant increased in June reaching 16.8%, while the rampant variant is the English variant (74.92%)
Web Content Article
ISS
, June 25th 2021
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Press notes
Press Release N°42/2021 COVID-19, confirmed predominance of the Delta variant
Web Content Article
Data of the eighth Newsletter and of the
ISS
flash survey
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Press Release N°65/2021 A sequence attributable to the Omicron variant has been identified by the Italian network
Web Content Article
ISS
, November 27th 2021
Newsroom:
Press releases
Press notes
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Press Release No. 22/2021
Web Content Article
ISS
, April 2nd 2021
Newsroom:
Special on COVID-19
Press releases
Press Release N°48/2021 In the last 45 days, 98.4% of sequenced swabs tested positive for the Delta variant
Web Content Article
ISS
, October 1st 2021
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Release N°44/2021 In the last 45 days, 88.7% of sequenced swabs tested positive for the Delta variant
Web Content Article
ISS
, September 17th 2021 - According to the COVID-19 Integrated Surveillance
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Special on COVID-19 » Varianti del virus
F.A.Q.
Web Content Article
How does the
ISS
share COVID-19 integrated surveillance data?...What did the
ISS
do to facilitate access to COVID-19 data?...Does the...
Newsroom:
Special on COVID-19
Press Release N°47/2021 COVID-19: the main monitoring data from the Situation Room
Web Content Article
ISS
, October 1st 2021
Newsroom:
Press releases
Special on COVID-19
Can breastfeeding women be vaccinated against Sars-CoV-2?
Web Content Article
previously envisaged in the interim guidance by the Istituto Superiore di Sanità –
ISS
faq vaccini
vaccini
iss per covid 19
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini » FAQ vaccini
Press Release N° 29/2021 First National Study on the impact of COVID-19 vaccine: infections, hospitalization and deaths nosedive as the vaccination campaign forges ahead
Web Content Article
ISS
, 15.05.2021 - The risk of SARS-CoV-2 infection causing hospitalization and death...surveillance" drawn up by the Working Group of the Istituto Superiore di Sanità -...
Newsroom:
Special on COVID-19
Press releases
Press Release N°36/2021 COVID-19: The vaccine affords up to 100% protection against infections, hospitalization and death
Web Content Article
If the prescribed doses are completed, the vaccine against COVID-19 is approximately 80% effective in protecting against infection and up to 100%
Newsroom:
Special on COVID-19
Press releases
Special on COVID-19 » Vaccini
Press Release N°40/2021 In the last 45 days, 82.4% of sequenced swabs were positive for the Delta variant
Web Content Article
The data are contained in the seventh
ISS
Newsletter "Prevalence and distribution
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Release N°50/2021 COVID-19, the efficacy of mRna vaccines continues to be high
Web Content Article
ISS
, Ottobre 6th 2021 - In the initial months after vaccination protection from
Newsroom:
Special on COVID-19
Press releases
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » Cosa fa l'ISS
Press Release N° 33/2021 The integrated network for sequencing is ready
Web Content Article
The Network for immunological and virus surveillance, research and training
Newsroom:
Special on COVID-19
Press releases
Press Release N°38/2021 COVID-19, with the introduction of the ‘Colour Zones” 25,000 hospitalizations were avoided in the first month alone
Web Content Article
ISS
, August 2nd 2021, The measures introduced last autumn with the Decree of the...carried out by the Bruno Kessler Foundation, the Istituto Superiore di Sanità –...
Newsroom:
Press releases
Special on COVID-19
PRESS RELEASE N° 26/2021 Neutralizing antibodies against SARS-CoV-2 persist in the bloodstream for at least eight months after infection
Web Content Article
collaboration with the Istituto Superiore di Sanità (Italian National Institute of Health-
ISS
Newsroom:
Special on COVID-19
Press releases
Press Release N°35/2021 COVID-19: in Italy 57.8% of cases are due to the 'Alpha variant', while 22.7% are due to the 'Delta' variant
Web Content Article
In Italy as at June 22, the prevalence of the so-called 'Alpha variant' (B.1.1.7) of SARS-CoV-2 was 57.8%, down from 88.1% on 18 May
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Press Release N°39/2021 COVID-19: In the last 45 days, 69.2% of sequenced swabs were positive for the Delta variant
Web Content Article
In Italy, in the last 45 days, 69.2% of sequenced swabs tested positive for the delta variant, thus taking over the alpha variant which has stopped at 17.3%
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Release N°52/2021 COVID-19: the main monitoring data from the Situation Room
Web Content Article
ISS
, October 15th 2021
Newsroom:
Press releases
Special on COVID-19
Press Release No 03/2022 COVID-19:
ISS
flash survey.
Web Content Article
Leggi la flash survey completa Rome, 14 January 2022 In Italy on 03 January Omicron was the predominant variant of the virus, with an estimated prevalence of 81% and a regional variability between...
Newsroom:
Press releases
Press notes
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Press Release N°37/2021 COVID-19: in Italy with over 90% of cases, the 'Delta variant' has replaced the 'Alpha' variant
Web Content Article
In Italy, as at 20 July, the prevalence of the so-called 'Delta variant' of the SARS-CoV-2 virus was 94.8%, a sharp increase compared to the survey of 22 June
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Release N°60/2021 COVID-19: the main monitoring data from the Situation Room
Web Content Article
ISS
, November 19th 2021
Newsroom:
Press releases
Special on COVID-19
World Hand Hygiene Day 2021
Web Content Article
ISS
, 5 May 2021 – Every year, the 5th of May marks the day dedicated to the importance...hands, download the infographics produced by the Istituto Superiore di Sanità –...
Newsroom:
Special on COVID-19
178 thousand excess mortality cases since the beginning of the pandemic
Web Content Article
null null null
ISS
, 02 March 2022 Seventh ISTAT-
ISS
Report, in 2021 especially in...the National Statistics Institute (ISTAT) and the Istituto...
Newsroom:
Press notes
Special on COVID-19
Press Release N°64/2021 COVID-19: the main monitoring data from the Situation Room
Web Content Article
ISS
, November 26th 2021
Newsroom:
Press releases
Special on COVID-19
How is vaccine efficacy calculated?
Web Content Article
world' efficacy analysis, performed weekly by the Istituto Superiore di Sanità –
ISS
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
Vaccinated versus unvaccinated, a comparison between cases shows that the vaccine works
Web Content Article
ISS
, July 20th 2021 - If vaccinations in the population reach high levels of coverage
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
40 Entries
Per Page
4
Entries per Page
8
Entries per Page
20
Entries per Page
40
Entries per Page
60
Entries per Page
Showing 1 to 40 of 308 entries.
Previous Page
Page
1
Page
2
Page
3
...
Intermediate Pages Use TAB to navigate.
Page
4
Page
5
Page
6
Page
7
Page
8
Next Page
Hidden